1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Coya Therapeutics, Inc.

Coya Therapeutics, Inc.

COYA
Coya Therapeutics, Inc.US flagNASDAQ Capital Market
4.41
USD
-0.07
- -
80.30MMarket Cap

Income Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
6
4
8
+ Sales & Services Revenue
- -
- -
- -
6
4
8
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
-6
-4
-8
- Operating Expenses
- -
5
10
14
21
31
+ Selling, General & Admin
- -
2
5
8
9
11
+ Research & Development
- -
3
5
6
12
19
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-5
-10
-8
-17
-23
- Non-Operating (Income) Loss
- -
- -
2
-1
-2
-1
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
2
-1
-2
-1
Pretax Income
- -
-5
-12
-7
-16
-21
- Income Tax Expense (Benefit)
- -
- -
- -
1
-1
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-5
-12
-8
-15
-21
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-5
-12
-8
-15
-21
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-5
-12
-8
-15
-21
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-5
-12
-8
-15
-21
EBIT
- -
-5
-10
-8
-17
-23
EBITDA
- -
-5
-10
-8
-17
-23
EBITDA Margin (%)
- -
- -
- -
-131.22
-484.58
-283.52
EBITA
- -
-5
-10
-8
-17
-23
Gross Margin (%)
- -
- -
- -
100
100
100
Operating Margin (%)
- -
- -
- -
-131.67
-485.35
-283.87
Profit Margin (%)
- -
- -
- -
-133.08
-418.7
-267.14
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
7
3
10
15
17
Basic EPS, GAAP
- -
-0.74
-4.73
-0.79
-0.98
-1.27
Basic EPS from Cont Ops
- -
-0.74
-4.73
-0.79
-0.98
-1.27
Diluted Weighted Avg Shares
- -
7
3
10
15
17
Diluted EPS, GAAP
- -
-0.74
-4.73
-0.79
-0.98
-1.27
Diluted EPS from Cont Ops
- -
-0.74
-4.73
-0.79
-0.98
-1.27

Balance Sheet (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
9
5
7
41
44
50
+ Cash, Cash Equivalents & STI
9
4
6
33
38
47
+ Cash & Cash Equivalents
9
4
6
33
38
47
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
8
1
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
8
1
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
1
5
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
- -
- -
- -
Total Assets
9
5
8
41
44
50
+ Payables & Accruals
- -
1
4
4
3
5
+ Accounts Payable
- -
1
2
1
2
1
+ Accrued Taxes
- -
- -
- -
1
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
2
2
1
4
+ ST Debt
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
1
1
1
+ Deferred Revenue
- -
- -
- -
1
1
1
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
Total Current Liabilities
- -
1
4
5
4
6
+ LT Debt
- -
- -
13
- -
- -
- -
+ LT Borrowings
- -
- -
13
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
1
1
1
+ Accrued Liabilities
- -
- -
- -
1
1
1
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
13
1
1
1
Total Liabilities
- -
1
17
6
5
7
+ Preferred Equity and Hybrid Capital
9
9
9
- -
- -
- -
+ Share Capital & APIC
- -
- -
1
62
80
105
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
1
62
80
105
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-1
-6
-18
-26
-41
-62
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
8
4
-8
36
40
43
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
8
4
-8
36
40
43
Total Liabilities & Equity
9
5
8
41
44
50
Shares Outstanding
10
10
10
14
17
21
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
Net Debt
-9
-4
7
-33
-38
-47
Net Debt to Equity
-105.05
-119.11
-83.78
-91.56
-96.87
-108.82
Tangible Common Equity Ratio
-5.62
-107.47
-204.72
86.36
89.24
86.14
Current Ratio
19.57
3.99
1.88
8.15
11.59
8.5
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
- -
-5
-12
-8
-15
-21
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
4
1
3
7
+ Stock-Based Compensation
- -
- -
- -
1
3
4
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
4
1
- -
2
+ Chg in Non-Cash Work Cap
- -
1
1
-5
2
4
+ (Inc) Dec in Accts Receiv
- -
- -
- -
-8
8
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
- -
-5
3
+ Inc (Dec) in Accts Payable
- -
1
2
1
-1
1
+ Inc (Dec) in Other
- -
- -
- -
1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-4
-7
-11
-10
-11
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
38
14
20
+ Increase in Capital Stock
- -
- -
- -
38
14
20
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
-1
-1
- -
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-1
-1
- -
-1
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
10
- -
- -
- -
+ Cash From Debt
- -
- -
10
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
-1
- -
2
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
- -
9
38
16
20
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
-4
2
27
6
8
EBITDA
- -
-5
-10
-8
-17
-23
EBITDA Margin (%)
- -
- -
- -
-131.22
-484.58
-283.52
Free Cash Flow
- -
-4
-7
-11
-10
-11
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-4
3
-20
-10
-11
Free Cash Flow per Basic Share
- -
-0.61
-2.79
-1.1
-0.68
-0.64
Price/Free Cash Flow
- -
- -
-1.7
-6.73
-8.49
-9.04
Cash Flow to Net Income
- -
0.8
0.59
1.4
0.69
0.51
Capital Expenditures
- -
- -
- -
- -
- -
- -